Skip to main content
Skip to footer
Opens in a new tab
About
Active Biotech in Brief
Management
Board of Directors
Goals and Strategy
Corporate Governance
Corporate Governance Report 2025
Article of Association
General Meetings
Audit committee
Scientific committee
Election Committee
Auditors
Projects
Our projects
Tasquinimod
Laquinimod
Naptumomab
Patents
Clinical Studies
Investor
Overview
Analyses and Presentations
Financial Calendar
Financial Reports
Shareholders
Events
Rights Issues
Rights Issue 2025
Media
Overview
Press Contact
Press Releases
Contact
Svenska
Q1
Q1
Press Release
Active Biotech Interim Report Q1 2026
Press Release
Active Biotech Interim Report Q1 2025
Press Release
Active Biotech Interim Report Q1 2024
Press Release
Active Biotech Interim Report Q1 2023
Press Release
Active Biotech Interim Report Q1 2022
Press Release
Active Biotech AB Interim report January – March 2021
Press Release
Active Biotech Interim Report January – March 2020
Press Release
Active Biotech AB – Interim report January – March 2019
Press Release
Active Biotech AB Interim report January – March 2018
Press Release
Active Biotech: Interim report January – March 2017
Show more
